Brief: Shenzhen Neptunus Interlong Bio-Technique Says Unit Entered Technology Transfer Agreement With Neptunus Research
29/04/2020 16:14
April 29 (Reuters) - Shenzhen Neptunus Interlong
Bio-technique Co Ltd 8329.HK :
* SHENZHEN NEPTUNUS INTERLONG BIO-TECHNIQUE CO LTD- UNIT
ENTERED
INTO TECHNOLOGY TRANSFER AGREEMENT WITH NEPTUNUS RESEARCH
* SHENZHEN NEPTUNUS INTERLONG BIO-TECHNIQUE- PARTIES TO
TRANSFER
NEPTINIB PHARMACEUTICAL TECHNOLOGY FROM NEPTUNUS RESEARCH TO
NEPTUNUS FUYAO
* SHENZHEN NEPTUNUS INTERLONG BIO-TECHNIQUE CO LTD-
CONSIDERATION
OF RMB17 MILLION
Source text for Eikon: ID:nHKS6zx1Mt
Further company coverage: 8329.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shenzhen Neptunus Interlong Bio-technique
See all newsBrief: Shenzhen Neptunus Interlong Bio-Technique's Unit Enters Into JV Agreement With Huikang Bio-Technology
China's Neptunus Interlong H1 revenue falls
Brief: Shenzhen Neptunus Interlong Bio-Technique Expects Net Profit Attributable To Owners Of RMB 7 Million For 2026 Interim Period
Brief: Shenzhen Neptunus Interlong Bio-Technique Posts FY Loss & Total Comprehensive Expenses Attributable RMB40.7 Million
Brief: Shenzhen Neptunus Interlong Bio-Technique Sees FY Net Loss Attributable Of RMB40 Million